Showing results (1551-1560 of 1,565) with videos related to

Sort By:
Pageof 157
Nature Methods|May 14, 2024
OpenFold: retraining AlphaFold2 yields new insights into its learning mechanisms and capacity for generalizationGustaf Ahdritz, Nazim Bouatta, Christina Floristean, et al.
Journal of Medicinal Chemistry|December 14, 2016
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity RelationshipJames Cook, F Christopher Zusi, Ivar M McDonald, et al.
The Journal of Infectious Diseases|November 23, 2023
Variant-Specific IgA Protects Against Omicron InfectionYun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.
Cell|May 11, 2021
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytiaDaniel Asarnow, Bei Wang, Wen-Hsin Lee, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTKAnurag S Srivastava, Soo Ko, Scott H Watterson, et al.
Journal of Medicinal Chemistry|August 29, 2014
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidateWilliam N Washburn, Mark Manfredi, Pratik Devasthale, et al.
Science Translational Medicine|November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infectionChristopher D Petro, Andrea T Hooper, Avery Peace, et al.
EMBO Molecular Medicine|January 7, 2022
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infectionMatthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, et al.
Clinical & Translational Immunology|August 26, 2022
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccineYun Shan Goh, Siew-Wai Fong, Angeline Rouers, et al.
Science Translational Medicine|January 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodiesDimitris Skokos, Janelle C Waite, Lauric Haber, et al.
Pageof 157